751 related articles for article (PubMed ID: 30087046)
1. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
[TBL] [Abstract][Full Text] [Related]
2. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
3. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.
Ma C; Pan Y; Zhang L; Zhang Y; Wu S; Sun Y; Duan W; Zhang M; Wang Q; Yang P
Hum Vaccin Immunother; 2017 Oct; 13(10):2379-2384. PubMed ID: 28846480
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
[TBL] [Abstract][Full Text] [Related]
6. Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China.
Zhang L; Pan Y; Ma C; Duan W; Sun Y; Wu S; Zhang M; Tian Y; Zheng Y; Yang P; Wang Q
Hum Vaccin Immunother; 2018 Jun; 14(6):1323-1330. PubMed ID: 29461909
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
[TBL] [Abstract][Full Text] [Related]
8. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
10. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
11. The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
Zhang L; Pan Y; Hackert V; van der Hoek W; Meijer A; Krafft T; Yang P; Wang Q
Vaccine; 2018 Aug; 36(33):4993-5001. PubMed ID: 30017144
[TBL] [Abstract][Full Text] [Related]
12. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A;
Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622
[TBL] [Abstract][Full Text] [Related]
14. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
16. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
18. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
Flannery B; Kondor RJG; Chung JR; Gaglani M; Reis M; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Kim SS; Blanton L; Kniss K; Budd AP; Brammer L; Stark TJ; Barnes JR; Wentworth DE; Fry AM; Patel M
J Infect Dis; 2020 Jan; 221(1):8-15. PubMed ID: 31665373
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
[TBL] [Abstract][Full Text] [Related]
20. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
